The Broader Market Backdrop
The current market posture is heavily front-loaded with anticipation around Nvidia's earnings release, which has effectively become the gravitational center for short-term price action. Heading into a holiday weekend, the NASDAQ is pushing higher while the S&P 500 sits relatively unchanged on the week, leaving traders with a compressed window to position before a single catalyst potentially redraws the landscape. The expectation is that there will be buy-side activity overnight, followed by sell-side flow into the following session—a typical setup when the entire market is pinning its hopes on one earnings print needing to be "absolutely spectacular." Beyond that single event, however, there are three distinct opportunities worth dissecting across consumer, healthcare, and old-guard technology.
Nike: A Bruised Name Searching for a Floor
Nike has been one of the most punished large-cap names in recent memory. The stock is down roughly 32% on the year, has shed about 46% from its recent highs, and—when viewed against its all-time peak—is now off by more than 70%, a drawdown not seen since 2021. Yet within that broader weakness, a tactical opportunity is taking shape on the shorter time horizon.
A 15-year weekly chart shows that the area near $40 was the location of a significant series of highs going back to 2013. The classic technical question now arises: can old resistance become new support? In the shorter term, a downward-sloping channel has formed after the post-earnings decline. Prices rallied back toward the initial highs that followed the March 31st gap down, then made fresh lows before stabilizing. The $41–$42 zone is acting as a supportive shelf, with closing prices largely holding that level even after brief dips below it. A move higher could see $47 come back into view as the old post-gap high, with full gap fill landing near $51.69.
Momentum signals corroborate the case for a near-term bounce. Price is now crossing above the short-term 5-day weekly EMA around $42.62, and RSI is breaking above a modestly sloping downtrend line, on pace for new relative highs. The volume profile also reveals a significant node at the lows—heavy volume coinciding with stable prices, a textbook signature of base formation between $42.50 and $45.50.
The trade structure to express this view is a tight, defined-risk bullish call spread targeting the June 18th expiration: buying the 42.50 calls and selling the 45 calls, a $2.50-wide spread for an $0.87 debit. That risk-one-to-make profile is well-suited to a stock that has earned the benefit of skepticism—it bets on a modest mean-reversion bounce above $45 rather than a sweeping reversal of the longer-term downtrend.
CVS: Standing Against the Momentum
CVS presents the inverse setup. The name is up roughly 49% over the trailing twelve months and remains higher by about 19% on the year, but it has recently pulled back almost 4% from its highs. The critical observation is psychological: CVS made a run at the $100 mark, topped out near $98 and change, and then began to fade. Failures at round-number resistance often mark inflection points, especially when momentum was already cooling.
The chart reinforces this view. Price broke above a repeated resistance area near $84, then ran sharply higher in a steep uptrend that has since been broken. The resulting consolidation looks like a bull flag or bull pennant, and the next move depends on which boundary breaks first. A bullish resolution requires a push above the recent high, while a bearish resolution becomes operative on a break of the $93.92–$94 lows, where a cascade of stop orders could accelerate the move lower.
Moving averages are slipping in concert with this read. Price is now trading just below the 5-day weekly EMA at $94.86, an early warning of trend change. Below that, the 21-day EMA sits near $88.86, and RSI has fallen out of overbought territory—another bearish tell. Volume profile points to a node at $94–$95.50, with a thinner pocket between $90.50 and $93 and additional volume around $87–$88 that could serve as the next supportive shelf.
The execution here is a bearish put spread to the June 18th expiration: buying the 94 put and selling the 90 put, a $4-wide spread purchased for a $1.50 debit. Max loss is capped at $1.50, and the position pays off if CVS rolls over and tests the $90 level, something that—given the failed momentum—could plausibly play out inside a trading day or two.
Cisco: Standing in Front of a Freight Train
Cisco is the most ambitious of the three setups, and explicitly framed as such. The stock has rallied roughly 27% in a single month and is up approximately 82.5% over the trailing 52 weeks. On a 5-year chart, the recent surge from $90 to $120 looks parabolic—almost vertical—a wall of buying that has taken the name beyond anything resembling recent resistance, with $119.39 marking the new high.
The thesis underlying this rally is essentially a derivative AI trade: the assumption that hyperscalers will continue spending at an insane pace, with capital flowing into legacy infrastructure names like Cisco (and even Intel) when capacity demand pushes investors back into "old tech." Eventually, the question of profitability has to resurface, and that capital expenditure will need to translate into earnings rather than perpetually growing debt-financed buildouts. The dark joke that captures the moment: "We may be unprofitable, but we'll make it up on volume."
Technically, the setup resembles the CVS chart in structure—a large gap up followed by a brief consolidation, this time more in the shape of a bull pennant. A break above $119 would confirm bullish continuation; a break of the $114 lows would open the door to a sharp decline, with gap fill landing near $102. Price sits above the 5-day EMA at $114, but the 21-day EMA is far below at $101—right around the gap-fill zone. RSI remains in overbought territory above 79.5, and a cross below its uptrend line and the 70 midline would mark the bearish trigger. Volume profile shows concentrated trading at $116 to $118.50 and a narrow node near $99 that could act as a downside magnet.
Because fighting a parabolic move requires duration, this trade extends out to the August 21st expiration: buying the 110 put and selling the 100 put, a $10-wide spread for a $3.15 debit. It is consciously a swing-for-the-fences bet, granting the position roughly three months for the price action to resolve. There is full acceptance that the stock may continue higher in the near term—the only requirement for the trade to pay off in full is that Cisco trade below $100 by August expiration.
The Common Thread
What ties these three trades together is a disciplined use of vertical spreads to define risk and curb volatility exposure, paired with technical setups that each tell a distinct story. Nike represents the mean-reversion bounce off a long-tested floor; CVS represents the failed breakout that punishes the late buyer at psychological resistance; and Cisco represents the contrarian fade against a parabolic blow-off, hedged with enough time for sanity to reassert itself. Each structure matches its conviction—tight and short-dated where the catalyst is imminent, wider and longer-dated where the move requires patience. In a market increasingly held hostage to a single earnings event, that kind of structural discipline is what separates a trade from a gamble.